Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2020 Results: May 5, 2020
12:00pm, Friday, 03'rd Apr 2020
Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2020 financial results at 6:00 am EDT on Tuesday, May 5, 2020. The Company will hold a
Franklin Resources Inc. Sells 3,190 Shares of Haemonetics Co. (NYSE:HAE)
10:50am, Friday, 03'rd Apr 2020
Franklin Resources Inc. decreased its holdings in Haemonetics Co. (NYSE:HAE) by 0.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,023,280 s
Alliancebernstein L.P. Sells 16,360 Shares of Haemonetics Co. (NYSE:HAE)
08:40am, Friday, 03'rd Apr 2020
Alliancebernstein L.P. cut its stake in Haemonetics Co. (NYSE:HAE) by 9.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).
Haemonetics acquires enicor GmbH HAE
11:40am, Thursday, 02'nd Apr 2020
Haemonetics acquires enicor GmbH HAE
BRIEF-Haemonetics Acquires Enicor GmbH To Expand Advanced Viscoelastic Testing Portfolio
11:13am, Thursday, 02'nd Apr 2020
Haemonetics Corp:
Haemonetics Reports Purchase Of enicor, No Terms Disclosed
10:47am, Thursday, 02'nd Apr 2020Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
10:45am, Thursday, 02'nd Apr 2020
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that it has acquired en
Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
12:00am, Thursday, 02'nd Apr 2020Medtronic's Evolut TAVR System Shows Positive Study Results
09:37pm, Monday, 30'th Mar 2020
Medtronic (MDT) presents favorable study outcomes for its Evolut TAVR system, which is expected to offer better treatment options to low-risk bicuspid aortic valve stenosis patients.
Medtronic's Evolut TAVR System Shows Positive Study Results
09:37pm, Monday, 30'th Mar 2020
Medtronic (MDT) presents favorable study outcomes for its Evolut TAVR system, which is expected to offer better treatment options to low-risk bicuspid aortic valve stenosis patients.
BRIEF-Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer
09:25pm, Monday, 30'th Mar 2020
Haemonetics Corp:
Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer
08:24pm, Monday, 30'th Mar 2020Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer
08:15pm, Monday, 30'th Mar 2020
Haemonetics Corporation (NYSE: HAE) today announced that it has appointed Anila Lingamneni Executive Vice President and Chief Technology Officer, effective April 1, 2020. She will report directly to C
Haemonetics (HAE) Upgraded to Buy: Here's What You Should Know
04:00pm, Monday, 30'th Mar 2020
Haemonetics (HAE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
